搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Rhodococcus opacus 3-isopropylmalate dehydrogenase (leuB) CSB-YP506050RLN
CSB-EP506050RLN
CSB-BP506050RLN
CSB-MP506050RLN
CSB-EP506050RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus Ribonuclease HII (rnhB) CSB-YP506051RLN
CSB-EP506051RLN
CSB-BP506051RLN
CSB-MP506051RLN
CSB-EP506051RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus Ribosome-binding factor A (rbfA) CSB-YP506052RLN
CSB-EP506052RLN
CSB-BP506052RLN
CSB-MP506052RLN
CSB-EP506052RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus Probable transcriptional regulatory protein ROP_68700 (ROP_68700) CSB-YP506053RLN
CSB-EP506053RLN
CSB-BP506053RLN
CSB-MP506053RLN
CSB-EP506053RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus 3-dehydroquinate synthase (aroB) CSB-YP506054RLN
CSB-EP506054RLN
CSB-BP506054RLN
CSB-MP506054RLN
CSB-EP506054RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus 50S ribosomal protein L9 (rplI) CSB-YP506055RLN
CSB-EP506055RLN
CSB-BP506055RLN
CSB-MP506055RLN
CSB-EP506055RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus Putative membrane protein insertion efficiency factor (ROP_34800) CSB-YP506056RLN
CSB-EP506056RLN
CSB-BP506056RLN
CSB-MP506056RLN
CSB-EP506056RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus Lysylphosphatidylglycerol biosynthesis bifunctional protein LysX (lysX), partial CSB-YP506057RLN
CSB-EP506057RLN
CSB-BP506057RLN
CSB-MP506057RLN
CSB-EP506057RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus Type III pantothenate kinase (coaX) CSB-YP506058RLN
CSB-EP506058RLN
CSB-BP506058RLN
CSB-MP506058RLN
CSB-EP506058RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus 4-hydroxy-2-oxovalerate aldolase 3 (ROP_44500) CSB-YP506059RLN
CSB-EP506059RLN
CSB-BP506059RLN
CSB-MP506059RLN
CSB-EP506059RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Trigger factor (tig) CSB-YP506060FMX
CSB-EP506060FMX
CSB-BP506060FMX
CSB-MP506060FMX
CSB-EP506060FMX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 3-oxoacyl-[acyl-carrier-protein] synthase 3 (fabH) CSB-YP506061FMX
CSB-EP506061FMX
CSB-BP506061FMX
CSB-MP506061FMX
CSB-EP506061FMX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Ketol-acid reductoisomerase (ilvC) CSB-YP506062FMX
CSB-EP506062FMX
CSB-BP506062FMX
CSB-MP506062FMX
CSB-EP506062FMX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae tRNA (guanine-N (7)-)-methyltransferase CSB-YP506063FMX
CSB-EP506063FMX
CSB-BP506063FMX
CSB-MP506063FMX
CSB-EP506063FMX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae UvrABC system protein C (uvrC), partial CSB-YP506064FMX
CSB-EP506064FMX
CSB-BP506064FMX
CSB-MP506064FMX
CSB-EP506064FMX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae UDP-N-acetylmuramoylalanine--D-glutamate ligase (murD) CSB-YP506065FMX
CSB-EP506065FMX
CSB-BP506065FMX
CSB-MP506065FMX
CSB-EP506065FMX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae S-adenosylmethionine synthase (metK) CSB-YP506066FMX
CSB-EP506066FMX
CSB-BP506066FMX
CSB-MP506066FMX
CSB-EP506066FMX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Septation ring formation regulator EzrA (ezrA), partial CSB-YP506067FMX
CSB-EP506067FMX
CSB-BP506067FMX
CSB-MP506067FMX
CSB-EP506067FMX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 30S ribosomal protein S20 (rpsT) CSB-YP506068FMX
CSB-EP506068FMX
CSB-BP506068FMX
CSB-MP506068FMX
CSB-EP506068FMX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Methylenetetrahydrofolate--tRNA- (uracil-5-)-methyltransferase TrmFO CSB-YP506069FMX
CSB-EP506069FMX
CSB-BP506069FMX
CSB-MP506069FMX
CSB-EP506069FMX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>